SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $507,000 | -85.8% | 14,459 | -86.5% | 0.03% | -87.9% |
| Q4 2018 | $3,562,000 | -49.9% | 107,221 | -24.1% | 0.28% | -37.9% |
| Q3 2018 | $7,110,000 | -26.0% | 141,216 | -12.1% | 0.45% | -30.4% |
| Q2 2018 | $9,614,000 | +3569.5% | 160,634 | +2708.3% | 0.65% | +3522.2% |
| Q1 2018 | $262,000 | -40.5% | 5,720 | -48.2% | 0.02% | -37.9% |
| Q4 2017 | $440,000 | – | 11,035 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 699,432 | $35,216,000 | 4.25% |
| Provident Investment Management, Inc. | 590,269 | $29,720,000 | 4.23% |
| CAPITAL MANAGEMENT CORP /VA | 225,232 | $11,340,000 | 2.90% |
| FALCON POINT CAPITAL, LLC | 188,341 | $9,483,000 | 2.04% |
| Ranger Investment Management | 600,464 | $30,233,000 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 471,260 | $23,728,000 | 1.96% |
| KOPP INVESTMENT ADVISORS LLC | 41,700 | $2,100,000 | 1.77% |
| SHAKER INVESTMENTS LLC/OH | 49,617 | $2,498,000 | 1.54% |
| Bruce & Co., Inc. | 148,058 | $7,454,000 | 1.44% |
| Bridge City Capital, LLC | 45,843 | $2,308,000 | 1.43% |